Contact Information I Facilities I Site Map I © 2011 Plant Response Biotech
The technology developed by Plant Response shows great promise to investors.
The molecular nature of the elicitors developed by Plant Response Biotech has a unique benefit for the commercialization and market potential of this technology. These products are of natural origin (e.g. microbes) and are not derived from chemical synthesis at industrial pipelines. The Elicitors nature gives this products competitive advantages respect to other chemical derived- crop protection strategies.
The progressive restriction and future ban of plant pesticides derived from the novel European environmental and health protection rules (the REACH rules) will eliminate from the market a significant number of fungicides and insecticides used currently for protection of relevant crops. This situation opens novel opportunities for crop protection strategies, such as those developed by Plant Response Biotech.
The potential market for this new generation of elicitors could reach the 5-7% of the actual fungicides/pesticides plus agro-nutrients sales in the next 5 years . Additionally, the identification and characterization of Plant Receptors for Elicitors will open new business opportunities for this technology.
The strategic alliances of Plant Response Biotech with research leader groups in the plat innate immunity field, currently under negotiation, as well as increasing the number of agreements with crop protection marketing companies, as well as those already established, will contribute to speed- up the target/lead discovery and their market commercialization.
Value to the stockholders is achieved through royalty-generating licensing agreements with crop protection companies.
plant response biotech
